Trastuzumab significantly improves survival in resectable HER-2 positive gastric cancer: A retrospective study.

Turk J Surg · 2025 · PMC11878183 · PMID 40012328

Europe PMC DOI

hedged sentence

0.1340

closest p · 2.7× alpha

0.1340

boldest claim

The sentences

did not reach statistical significancep=0.134not close (p > 0.1)

39.6 months in tumors ≤4 cm), but this did not reach statistical significance in multivariate analysis (HR=2.195, 95% CI: 0.785-6.135, p=0.134).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.